GlassScriptPhysician profile
Brooke Jones
NPI 1285219592
$1,011.04
in general payments reported to CMS, 2019-2025
16 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Psychiatric/Mental Health (Registered Nurse) provider received nationally (typical 2025 total: $137).
See the full distribution for Psychiatric/Mental Health (Registered Nurse)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $58.26 · 2023: $303 · 2024: $350 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $196.19 | 2024-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Janssen Biotech, INC. | $191.94 | 2022-2025 | Darzalex, Tecvayli, Talvey |
| Exelixis INC. | $118.46 | 2023 | Cabometyx |
| Novartis Pharmaceuticals Corporation | $98.43 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $82.28 | 2025 | Exparel, Iovera |
| Janssen Pharmaceuticals, INC | $59.80 | 2023 | Invega |
| Pharmacyclics LLC, An Abbvie Company | $54.83 | 2023 | Imbruvica, Epkinly |
| Abbvie INC. | $50.62 | 2024-2025 | |
| Ucb, INC. | $35.52 | 2024 | Bimzelx |
| Pharmacosmos Therapeutics INC. | $22.05 | 2025 | Monoferric |
| Otsuka America Pharmaceutical, INC. | $20.10 | 2022 | |
| Lundbeck LLC | $19.33 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.57 | 2023 | Uzedy |
| Genentech USA, INC. | $15.76 | 2023 | Rozlytrek, Gavreto, Avastin |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.74 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $13.42 | 2024 | Optune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.